Figure 3a–d shows proportions of severe ROP in the AA/DHA supplemented and control infants according to high CRP (during the first postnatal week) or/and thrombocytopenia (during the first four postnatal weeks). This evidence concerns the gene CRP and retinopathy of prematurity.